Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat vs Epoetin Alpha for Anemia in Non-Dialysis CKD
NCT07755683Not yet recruiting
- Sponsor
- Services Hospital Lahore
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of daprodustat in anemia of chronic kidney disease (2 arms), sponsored by Services Hospital Lahore. Primary endpoints: Hemoglobin Levels at 1 month and Serum Ferritin Levels at 1 month. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT07755683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07755683.